It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MCRPF’s FA Score shows that 1 FA rating(s) are green whileMDRSF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MCRPF’s TA Score shows that 4 TA indicator(s) are bullish.
MCRPF (@Medical/Nursing Services) experienced а 0.00% price change this week, while MDRSF (@Medical/Nursing Services) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was +0.41%, and the average quarterly price growth was +3.73%.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
MCRPF | MDRSF | MCRPF / MDRSF | |
Capitalization | 3.06B | 1.22B | 250% |
EBITDA | N/A | N/A | - |
Gain YTD | 118.293 | 0.000 | - |
P/E Ratio | N/A | 196.01 | - |
Revenue | N/A | N/A | - |
Total Cash | N/A | N/A | - |
Total Debt | N/A | N/A | - |
MCRPF | MDRSF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 41 | |
SMR RATING 1..100 | 96 | 92 | |
PRICE GROWTH RATING 1..100 | 35 | 73 | |
P/E GROWTH RATING 1..100 | 2 | 100 | |
SEASONALITY SCORE 1..100 | n/a | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCRPF's Valuation (86) in the null industry is in the same range as MDRSF (91). This means that MCRPF’s stock grew similarly to MDRSF’s over the last 12 months.
MDRSF's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for MCRPF (100). This means that MDRSF’s stock grew somewhat faster than MCRPF’s over the last 12 months.
MDRSF's SMR Rating (92) in the null industry is in the same range as MCRPF (96). This means that MDRSF’s stock grew similarly to MCRPF’s over the last 12 months.
MCRPF's Price Growth Rating (35) in the null industry is somewhat better than the same rating for MDRSF (73). This means that MCRPF’s stock grew somewhat faster than MDRSF’s over the last 12 months.
MCRPF's P/E Growth Rating (2) in the null industry is significantly better than the same rating for MDRSF (100). This means that MCRPF’s stock grew significantly faster than MDRSF’s over the last 12 months.
MCRPF | MDRSF | |
---|---|---|
RSI ODDS (%) | 4 days ago57% | N/A |
Stochastic ODDS (%) | 4 days ago63% | N/A |
Momentum ODDS (%) | 4 days ago55% | N/A |
MACD ODDS (%) | 4 days ago47% | N/A |
TrendWeek ODDS (%) | 4 days ago48% | 4 days ago5% |
TrendMonth ODDS (%) | 4 days ago52% | 4 days ago6% |
Advances ODDS (%) | 11 days ago53% | N/A |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | 4 days ago37% | N/A |
Aroon ODDS (%) | 4 days ago63% | N/A |
A.I.dvisor tells us that MCRPF and LDDD have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCRPF and LDDD's prices will move in lockstep.
Ticker / NAME | Correlation To MCRPF | 1D Price Change % | ||
---|---|---|---|---|
MCRPF | 100% | N/A | ||
LDDD - MCRPF | 21% Poorly correlated | N/A | ||
NHNKF - MCRPF | 1% Poorly correlated | N/A | ||
NNCSF - MCRPF | 1% Poorly correlated | N/A | ||
MRCHF - MCRPF | -0% Poorly correlated | N/A | ||
MDRSF - MCRPF | -0% Poorly correlated | N/A | ||
More |
A.I.dvisor indicates that over the last year, MDRSF has been loosely correlated with STIM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MDRSF jumps, then STIM could also see price increases.
Ticker / NAME | Correlation To MDRSF | 1D Price Change % | ||
---|---|---|---|---|
MDRSF | 100% | N/A | ||
STIM - MDRSF | 40% Loosely correlated | +3.12% | ||
LUCY - MDRSF | 28% Poorly correlated | -0.51% | ||
NHNKY - MDRSF | 11% Poorly correlated | +1.00% | ||
LZAGY - MDRSF | 4% Poorly correlated | -1.21% | ||
NHNKF - MDRSF | 0% Poorly correlated | N/A | ||
More |